← back to search

Birgit Schittek

University of Tübingen · DE
Area of research
Molecular Biology · Oncology
Research interest
Research focused on Melanoma and PI3K/AKT/mTOR pathway, with related work in Protein kinase B, Antimicrobial peptides, Immune system. Notable publications include 'Lugdunin amplifies innate immune responses in the skin in synergy with host- and microbiota-derived factors', 'miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes', and 'PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo'.
h-index
citations
635
works
15
NIH funding
primary concept
email

Recent publications

NOD2-Induced IκBζ Mediates a Protective Host Response against Epicutaneous Staphylococcus aureus Infection
Journal of Investigative Dermatology 2025cited by 1position: middledoi
naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation
EMBO Reports 2024cited by 23position: middledoi
Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin Compaction
Journal of Investigative Dermatology 2024cited by 7position: middledoi
IL-17 Signaling in Keratinocytes Orchestrates the Defense against Staphylococcus aureus Skin Infection
Journal of Investigative Dermatology 2023cited by 11position: middledoi
Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors
International Journal of Radiation Oncology*Biology*Physics 2021cited by 13position: middledoi
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers
Cancers 2020cited by 24position: middledoi
Lugdunin amplifies innate immune responses in the skin in synergy with host- and microbiota-derived factors
Nature Communications 2019cited by 139position: lastdoi
PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases <i>In Vitro</i> and <i>In Vivo</i>
Clinical Cancer Research 2016cited by 100position: middledoi
522 Induction of the progeroid/cancer prone XP-like phenotype by an antimycotic drug is mediated via reversible downregulation of DNA repair, an update
Journal of Investigative Dermatology 2016cited by 0position: middledoi
Processing of Laminin α Chains Generates Peptides Involved in Wound Healing and Host Defense
Journal of Innate Immunity 2014cited by 53position: lastdoi
Quantitative Proteomics of the Human Skin Secretome Reveal a Reduction in Immune Defense Mediators in Ectodermal Dysplasia Patients
Journal of Investigative Dermatology 2014cited by 31position: lastdoi
YBX1 Is a Modulator of MIA/CD-RAP-Dependent Chondrogenesis
PLoS ONE 2013cited by 17position: middledoi
Melanoma inhibitory activity promotes melanoma development through activation of <scp>YBX</scp>1
Pigment Cell & Melanoma Research 2013cited by 10position: middledoi
miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes
Journal of Investigative Dermatology 2012cited by 139position: middledoi
MAPK and PI3K/AKT mediated YB‐1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop
Experimental Dermatology 2012cited by 67position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Tobias Sinnberg · University Children's Hospital Tübingen3 papers (2012–2016)Anja‐Katrin Bosserhoff · University of Regensburg3 papers (2012–2013)Martin Schaller · Hautklinik Heidelberg3 papers (2014–2020)Jule Focken · University of Tübingen2 papers (2019–2024)Rainer Schmid · University of Regensburg2 papers (2013–2013)Florian C. Kurschus · Johannes Gutenberg University Mainz2 papers (2019–2023)Claus Garbe · STZ eyetrial2 papers (2014–2016)Daniel Zips · Auguste-Viktoria-Klinik2 papers (2020–2021)Rainer Spang · University of Regensburg2 papers (2013–2013)Sonja Moos · Johannes Gutenberg University Mainz2 papers (2019–2023)Daniela Kramer · Johannes Gutenberg University Mainz2 papers (2024–2025)Francesca Bork · University of Tübingen2 papers (2024–2025)Mark Berneburg · University of Regensburg2 papers (2014–2016)Birgit Fehrenbacher · University of Tübingen2 papers (2016–2020)Alexander N.R. Weber · German Cancer Research Center2 papers (2024–2025)Corinna Kosnopfel · University of Tübingen2 papers (2020–2021)Mahmoud Toulany · University of Wisconsin–Madison2 papers (2020–2021)Birgit Sauer · University of Tübingen2 papers (2012–2019)Katharina Meyer · Johannes Gutenberg University Mainz2 papers (2013–2013)Hubert Kalbacher · University of Tübingen2 papers (2014–2019)